RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 84 filers reported holding RAPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $349,802 | -5.7% | 21,047 | +6.1% | 0.00% | – |
| Q2 2023 | $370,878 | +65.3% | 19,833 | +62.2% | 0.00% | – |
| Q1 2023 | $224,320 | +10.2% | 12,226 | +19.0% | 0.00% | – |
| Q4 2022 | $203,505 | -6.2% | 10,278 | +14.1% | 0.00% | – |
| Q3 2022 | $217,000 | +40.0% | 9,010 | +6.4% | 0.00% | – |
| Q2 2022 | $155,000 | -0.6% | 8,465 | +19.4% | 0.00% | – |
| Q1 2022 | $156,000 | -40.2% | 7,088 | -0.3% | 0.00% | – |
| Q4 2021 | $261,000 | +18.6% | 7,111 | +0.6% | 0.00% | – |
| Q3 2021 | $220,000 | +129.2% | 7,066 | +131.9% | 0.00% | – |
| Q2 2021 | $96,000 | +81.1% | 3,047 | +27.3% | 0.00% | – |
| Q1 2021 | $53,000 | +103.8% | 2,394 | +78.8% | 0.00% | – |
| Q4 2020 | $26,000 | -39.5% | 1,339 | 0.0% | 0.00% | – |
| Q3 2020 | $43,000 | -17.3% | 1,339 | -25.9% | 0.00% | – |
| Q2 2020 | $52,000 | +940.0% | 1,808 | +577.2% | 0.00% | – |
| Q1 2020 | $5,000 | -28.6% | 267 | 0.0% | 0.00% | – |
| Q4 2019 | $7,000 | – | 267 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $29,189,000 | 46.08% |
| KPCB XV Associates, LLC | 1,297,063 | $23,671,000 | 43.66% |
| Column Group LLC | 2,680,458 | $48,918,000 | 10.41% |
| Ponoi II Management, LLC | 145,401 | $2,654,000 | 7.21% |
| Euclidean Capital LLC | 432,900 | $7,900,000 | 6.72% |
| AJU IB Investment Co., Ltd. | 99,503 | $1,816,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,023,321 | $18,676,000 | 3.17% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $8,096,000 | 1.62% |
| Ghost Tree Capital, LLC | 165,000 | $3,011,000 | 1.57% |
| Perceptive Advisors | 1,913,791 | $34,927,000 | 1.09% |